KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 111 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,279,000 | -7.3% | 802,246 | -5.5% | 0.25% | -14.3% |
| Q1 2021 | $8,928,000 | -38.1% | 848,707 | -8.9% | 0.29% | -39.8% |
| Q4 2020 | $14,424,000 | +7.9% | 931,754 | +1.7% | 0.48% | -17.8% |
| Q3 2020 | $13,370,000 | -29.9% | 915,760 | -9.1% | 0.58% | -32.2% |
| Q2 2020 | $19,080,000 | +11.8% | 1,007,367 | +13.4% | 0.86% | -12.3% |
| Q1 2020 | $17,064,000 | +24.3% | 888,284 | +24.0% | 0.98% | +64.4% |
| Q4 2019 | $13,733,000 | +119.3% | 716,397 | +10.0% | 0.59% | +85.3% |
| Q3 2019 | $6,263,000 | – | 651,050 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |